Among American women, breast cancer is the most common cancer, after skin cancer. About 1 in 8 (12 percent) women in the U.S. will develop invasive breast cancer during their lifetime.
For 2018, the American Cancer Society estimates that:
Incidence rates of breast cancer are highest in non-Hispanic white women; however, breast cancer death rates are highest in African American women.
Source: American Cancer Society Breast Cancer Facts & Figures 2017-2018.
Breast cancer is the second leading cause of cancer death in women, surpassed only by lung cancer. Death rates from breast cancer have been declining since about 1989, with larger decreases in women younger than age 50. It is believed that earlier detection through screening and increased awareness, as well as improved treatment, has led to these decreases.
Today, there are more than 3.1 million breast cancer survivors in the U.S., including those still being treated and those who have completed treatment.
Source: American Cancer Society. Cancer Facts and Figures 2018. Atlanta, Ga: American Cancer Society; 2018.
The Association of Community Cancer Centers (ACCC) has joined with the Oncology Nursing Society (ONS) and The France Foundation to support a series of live Grand Rounds/Tumor Boards, “PARP Inhibitors: Advancing Personalized Medicine for Metastatic Breast Cancer Patients.”
ACCC member cancer programs are invited to participate in a live Grand Rounds program where a subject matter expert will travel to participating institutions to lead a one-hour accredited session. The Grand Rounds will provide the multidisciplinary cancer team with strategies to appropriately incorporate genetic testing and poly (ADP-ribose) polymerase (PARP) inhibitor therapy for patients with metastatic breast cancer (MBC).
The ongoing ACCC Metastatic Breast Cancer project is working to expand multidisciplinary team awareness of how to effectively meet the holistic needs of metastatic breast cancer patients, enhance patient-provider communication, and improve the patient-centeredness of care delivery. The project's latest publication, Metastatic Breast Cancer: Effective Principles in Action, builds on the six principles for reframing provider-patient conversations identified in the Metastatic Breast Cancer Workbook. Read how three cancer programs are integrating these principles as they advance their care for this patient population. Learn more.
"Dandelion Toolkit" QI Study
U.S.-based cancer programs and practices have the opportunity to join in a quality improvement (QI) study by testing the new “Dandelion Toolkit” designed to support clear communication, empowering both metastatic breast cancer patients and their healthcare providers. Toolkits provided to participants free of charge.
Learn More & Apply
To support quality improvement projects in breast cancer, the Association of Community Cancer Centers (ACCC) has joined with Pfizer Independent Grants for Learning and Change (IGLC) to issue a Request for Proposals (RFP) with the intent of funding QI initiatives that fully integrate BRCA testing into patient care plans in order to help inform the treatment decision-making process.
ACCC is partnering with AXIS Medical Education in an educational research project to assess the value of a robust, independent, quality-focused educational intervention that aims to improve a community cancer program's quality measures related to management of patients with HER2+ breast cancer (all stages). Two ACCC-member Cancer Programs are participating in the project.